The Anal Cancer/High-grade squamous intraepithelial lesions Outcomes Research (ANCHOR) trial demonstrated that treating precancerous anal HSIL reduces the incidence of anal cancer by 57% in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback